Skip to main content

Metapneumovirus clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for
  • Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

    Sorry, in progress, not accepting new patients

    The purpose of this study is to assess the safety and immunogenicity of mRNA-1365, an mRNA vaccine targeting respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) and mRNA-1345, an mRNA vaccine targeting RSV, in participants aged 5 months to <24 months.

    Los Angeles 5368361, California 5332921 and other locations

Last updated: